Hims & Hers Health, Inc. HIMS

Set alert

Price alert · HIMS

All alert types
25.24 USD -2.44 -8.82%

At close · Nov 2

25.30 +0.06 +0.24%

After hours · Nov 2, 7:59 PM ET

Bid
25.23 × 600
Ask
25.24 × 700
25.15 Day range 28.49
14.52 52-week range 45.46
YTD
-22.27%
1 year
-44.48%
Open
27.97
Prev close
27.68
Mkt cap
5.89B
Vol
10.78M
Avg vol
10.72M
EPS
-0.58
P/E
0.00
Div yield
0.00%
More statistics
Low
25.15
High
28.49
Forward P/E
34.23
Beta
2.50
Short ratio
5.12
Inst. own
71.89%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
29.04
200-d avg
27.03
1y target
31.15

MAX chart

Chart tools
Interval

Events in this range
  • Aug 4, 2025Earnings: 0.17; estimate 0.18; surprise -5.56%
  • Nov 3, 2025Earnings: 0.06; estimate 0.09; surprise -33.33%
  • Feb 23, 2026Earnings: 0.07; estimate 0.02; surprise 250%
  • May 11, 2026Earnings: -0.4; estimate 0.02537; surprise -1676.67%
  • Aug 10, 2026Earnings: -0.37; estimate -0.04979; surprise -643.12%
  • Aug 11, 2026Rating: TD Cowen · Hold → Hold
  • Aug 11, 2026Rating: B of A Securities · Neutral → Neutral
  • Aug 11, 2026Rating: Deutsche Bank · Hold → Hold
  • Aug 11, 2026Rating: Citigroup · Neutral → Neutral
  • Aug 21, 2026Rating: Barclays · Overweight → Overweight
  • Aug 24, 2026Rating: Truist Securities · Hold → Hold
Signals (128)
NameDateAgo
SMA: BearishOct 12, 20263 weeks ago
SMA: BearishOct 12, 20263 weeks ago
MACD: Sell SignalOct 12, 20263 weeks ago
SMA: BullishOct 5, 20264 weeks ago
MACD: Buy SignalOct 5, 20264 weeks ago
SMA: BearishSep 28, 20261 month ago
SMA: BullishSep 21, 20261 month ago
MACD: Sell SignalSep 7, 20261 month ago
SMA: BearishAug 24, 20262 months ago
SMA: BullishAug 17, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 3, 20263 months ago
SMA: BearishJul 20, 20263 months ago
SMA: BullishJun 15, 20264 months ago
SMA: BullishMay 25, 20265 months ago
SMA: BearishMay 18, 20265 months ago
SMA: BullishApr 6, 20267 months ago
MACD: Buy SignalApr 6, 20267 months ago
SMA: BearishMar 23, 20267 months ago
SMA: BullishMar 9, 20267 months ago

Newest 20 of 128.

Financial health

Altman Z-Score

1.45 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 57.0×
FY 2019: -4.8×FY 2020: -28.6×FY 2021: -11.3×FY 2022: -20.0×FY 2023: -80.9×FY 2024: 41.7×FY 2025: 57.0×
FY 2019 5y median -11.3× FY 2025
P/S 3.1×
FY 2019: 4.2×FY 2020: 3.5×FY 2021: 4.5×FY 2022: 2.5×FY 2023: 2.1×FY 2024: 3.5×FY 2025: 3.1×
FY 2019 5y median 3.1× FY 2025
P/B 13.5×
FY 2019: -2.5×FY 2020: -3.5×FY 2021: 3.7×FY 2022: 4.2×FY 2023: 5.4×FY 2024: 11.0×FY 2025: 13.5×
FY 2019 5y median 5.4× FY 2025
P/FCF 98.8×
FY 2019: -4.5×FY 2020: -76.9×FY 2021: -31.0×FY 2022: -38.8×FY 2023: 39.6×FY 2024: 26.3×FY 2025: 98.8×
FY 2019 5y median 26.3× FY 2025
EV/EBITDA 45.9×
FY 2019: -4.5×FY 2020: -34.7×FY 2021: -10.8×FY 2022: -21.8×FY 2023: -147×FY 2024: 56.4×FY 2025: 45.9×
FY 2019 5y median -10.8× FY 2025
EV/Sales 3.5×
FY 2019: 3.9×FY 2020: 3.3×FY 2021: 4.3×FY 2022: 2.4×FY 2023: 2.0×FY 2024: 3.4×FY 2025: 3.5×
FY 2019 5y median 3.4× FY 2025
FCF Yield 1.0%
FY 2019: -22.3%FY 2020: -1.3%FY 2021: -3.2%FY 2022: -2.6%FY 2023: 2.5%FY 2024: 3.8%FY 2025: 1.0%
FY 2019 5y median 1.0% FY 2025

Profitability

Gross Margin 73.8%
FY 2019: 54.0%FY 2020: 73.6%FY 2021: 75.2%FY 2022: 77.6%FY 2023: 82.0%FY 2024: 79.5%FY 2025: 73.8%
FY 2019 5y median 77.6% FY 2025
Operating Margin 4.5%
FY 2019: -90.1%FY 2020: -10.2%FY 2021: -42.3%FY 2022: -13.0%FY 2023: -3.4%FY 2024: 4.2%FY 2025: 4.5%
FY 2019 5y median -3.4% FY 2025
Net Margin 5.5%
FY 2019: -87.3%FY 2020: -12.2%FY 2021: -39.6%FY 2022: -12.5%FY 2023: -2.7%FY 2024: 8.5%FY 2025: 5.5%
FY 2019 5y median -2.7% FY 2025
ROE 23.7%
FY 2019: 53.3%FY 2020: 12.3%FY 2021: -32.2%FY 2022: -21.1%FY 2023: -6.8%FY 2024: 26.4%FY 2025: 23.7%
FY 2019 5y median -6.8% FY 2025
ROIC 6.0%
FY 2019: -140.5%FY 2020: -14.6%FY 2021: -32.6%FY 2022: -21.5%FY 2023: -8.3%FY 2024: 12.7%FY 2025: 6.0%
FY 2019 5y median -8.3% FY 2025
ROA 6.0%
FY 2019: -100.0%FY 2020: -15.3%FY 2021: -25.6%FY 2022: -17.9%FY 2023: -5.3%FY 2024: 17.8%FY 2025: 6.0%
FY 2019 5y median -5.3% FY 2025

Growth (YoY)

Revenue 59.0%
FY 2019: 0.0%FY 2020: 80.2%FY 2021: 82.8%FY 2022: 93.8%FY 2023: 65.5%FY 2024: 69.3%FY 2025: 59.0%
FY 2019 FY 2025
Operating Income 70.6%
FY 2019: 0.0%FY 2020: 79.6%FY 2021: -659.7%FY 2022: 40.3%FY 2023: 57.1%FY 2024: 310.2%FY 2025: 70.6%
FY 2019 FY 2025
EPS (diluted) -3.8%
FY 2019: 0.0%FY 2020: 75.4%FY 2021: -13.7%FY 2022: 44.8%FY 2023: 65.6%FY 2024: 581.8%FY 2025: -3.8%
FY 2019 FY 2025
Free Cash Flow -62.7%
FY 2019: 0.0%FY 2020: 91.2%FY 2021: -487.3%FY 2022: 14.3%FY 2023: 239.1%FY 2024: 322.1%FY 2025: -62.7%
FY 2019 FY 2025

Financial Health

Current Ratio 1.9×
FY 2019: 3.4×FY 2020: 7.4×FY 2021: 3.4×FY 2022: 4.5×FY 2023: 3.0×FY 2024: 1.8×FY 2025: 1.9×
FY 2019 5y median 3.0× FY 2025
Quick Ratio 1.6×
FY 2019: 3.2×FY 2020: 7.2×FY 2021: 3.2×FY 2022: 4.1×FY 2023: 2.7×FY 2024: 1.5×FY 2025: 1.6×
FY 2019 5y median 2.7× FY 2025
Debt / Equity 2.1×
FY 2019: -0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 2.1×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 5.0×
FY 2019: 0.3×FY 2020: 1.9×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 7.2×FY 2024: -2.4×FY 2025: 5.0×
FY 2019 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2019: -202×FY 2020: -1514×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31